IP Library Patent Application 15269455
Patent Application
App. No. 15/269,455

METHODS AND SYSTEMS FOR DIAGNOSING AND TREATING CHROMATIC ABERRATIONS OF AN EYE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/269,455
Abstract

Configurations are disclosed for a health system to be used in various healthcare applications, e.g., for patient diagnostics, monitoring, and/or therapy. The health system may comprise a light generation module to transmit light or an image to a user, one or more sensors to detect a physiological parameter of the user's body, including their eyes, and processing circuitry to analyze an input received in response to the presented images to determine one or more health conditions or defects.

Claims (45)

1 . (canceled)

2 . A wearable augmented reality device, the device comprising:

an augmented reality head-mounted ophthalmic system comprising a wearable augmented reality display platform configured to pass light from the world into an eye of a person wearing the head-mounted system, the augmented reality display platform comprising optics configured to output light to form an image in the eye,

wherein the augmented reality display platform is configured to output a first color component of the image with wavefront divergence corresponding to a first depth plane and a second color component of the image with wavefront divergence corresponding to a second depth plane different than the first depth plane to compensate for longitudinal chromatic aberration of the person's eye.

3 . The device of claim 2 , wherein the augmented reality display is configured to output a third color component of the image with wavefront divergence corresponding to a third depth plane different than the first and second depth planes to compensate for longitudinal chromatic aberration of the person's eye.

4 . The device of claim 2 , further comprising a user interface for receiving a prescription for the longitudinal chromatic aberration.

5 . The device of claim 2 , wherein the augmented reality head-mounted ophthalmic system is configured to conduct an eye exam by automatically varying a focus of light forming the image to provide incremental changes in optical prescription.

6 . The device of claim 5 , further comprising a biofeedback system configured to provide an input to the augmented reality head-mounted ophthalmic system, wherein the incremental change in the optical prescription is based on the input.

7 . The device of claim 6 , further comprising a biofeedback system configured to objectively monitor one or more properties of the eye, wherein the optical prescription is based on the monitored one or more properties.

8 . The device of claim 7 , wherein the biofeedback system receives inputs from at least one of a phoropter, an auto-refractor, and an eye tracking system.

9 . The device of claim 7 , wherein the one or more properties of the eye is at least one of: changes in a convergence point of the eye, changes in a position of a head of the person, and changes in a size of a pupil of the eye.

10 . The device of claim 5 , wherein the augmented reality head-mounted ophthalmic system is configured to conduct the eye exam by automatically varying a focus of light forming the first color component of the image to provide incremental change in optical prescription.

11 . The device of claim 10 , wherein the augmented reality head-mounted ophthalmic system is configured to conduct the eye exam by automatically varying a focus of light forming a monochromatic image of the second color component to provide incremental change in optical prescription.

12 . The device of claim 11 , wherein the augmented reality head-mounted ophthalmic system is configured to conduct the eye exam by automatically varying a focus of light forming a monochromatic image of a third color component of the image to provide incremental change in optical prescription.

13 . The device of claim 12 , wherein the images comprise letters.

14 . The device of claim 12 , wherein the images comprise graphic symbols, pictures, or drawings.

15 . The device of claim 5 , further comprising a user interface configured to receive input from the wear regarding the image.

16 . The device of claim 5 , wherein the augmented reality head-mounted ophthalmic system is configured to assess whether the person can view the image comfortably and incrementally increase the prescription, positive or negative, by changing focus if not.

17 . The device of claim 2 , wherein the wearable augmented reality display platform comprises a fiber scanning device.

18 . The device of claim 2 , wherein the wearable augmented reality device system is configured such that the angle at which light of different wavelengths is projected may be varied based lateral chromatic aberration.

19 . The device of claim 18 , wherein varying the angle at which light of different wavelengths is projected displaces an image formed by the light along the focal plane of the optics.

20 . The device of claim 18 , wherein the optics comprises an adaptable optics configured to receive an input and vary the angle at which light of the first color component is projected based on lateral chromatic aberration.

21 . The device of claim 2 , wherein the optics comprises an adaptable optics element configured to project the light.

22 . The device of claim 21 , wherein the adaptable optics element comprises a variable focus element.

23 . A wearable augmented reality device comprising:

an augmented reality head-mounted ophthalmic system comprising a wearable augmented reality display platform configured to pass light from the world into an eye of a person wearing the head-mounted system, the augmented reality display platform comprising optics configured to output light to form an image in the eye,

wherein the augmented reality display platform is configured to output light of a first color component of the image at a first angle and light of a second color component of the image at a second angle different than the first angle to compensate for lateral chromatic aberration of the person's eye.

24 . The device of claim 23 , further comprising a user interface for receiving a prescription for the lateral chromatic aberration.

25 . The device of claim 23 , wherein the augmented reality head-mounted ophthalmic system is configured to conduct an eye exam by automatically varying an angle of light forming the image to provide incremental change in optical prescription.

26 . The device of claim 25 , further comprising a biofeedback system configured to objectively monitor one or more properties of the eye, wherein the prescription is based on the monitored one or more properties of the eye.

27 . The device of claim 23 , further comprising one or more outwardly facing cameras configured to obtain an image of the world, wherein the image projected into the eye comprises the obtained image.

28 . A wearable device comprising:

a head-mounted ophthalmic system comprising:

a display platform comprising optics configured to output light to form an image in an eye of a person wearing the head-mounted ophthalmic system, and

a processor circuit configured to drive the optics based on an image modification program, wherein the image modification program is configured to compensate for chromatic aberration imparted on to the image by an optical surface.

29 . The device of claim 28 , wherein the head-mounted ophthalmic system further comprises a memory circuit operatively connected to the processor circuit and configured to store the image modification program.

30 . The device of claim 28 , wherein the image modification program is based on an optical prescription of the person, wherein the optical surface comprises a surface of the eye.

31 . The device of claim 30 , further comprising a biofeedback system configured to objectively monitor one or more properties of the eye, wherein the optical prescription is based on the monitored one or more properties of the eye.

32 . The device of claim 28 , wherein the image modification program is based on chromatic aberrations imparted on to the image by the optics, wherein the optical surface comprises a surface of the optics.

33 . The device of claim 28 , wherein the optics comprises a variable focus element, wherein the image modification program is configured to drive the variable focus element by selectively outputting light of a first color component of the image with a wavefront divergence corresponding to a first depth plane and light of a second color component of the image with a wavefront divergence corresponding to a second depth plane different than the first depth plane to compensate for longitudinal chromatic aberrations.

34 . A wearable device comprising:

a head-mounted ophthalmic system comprising a display platform, the display platform comprising optics configured to output light to form an image in an eye of a person wearing the device,

wherein the display platform is configured to project light of a first color component of the image at a first intensity and light of a second color component of the image at a second intensity different than the first intensity to compensate for chromatic aberration of the person's eye.

35 . The device of claim 34 , wherein the chromatic aberrations of the person's eye causes the light of the first color component to focus in front of a retina of the eye, wherein the first intensity is greater than the second intensity.

36 . The device of claim 34 , wherein the chromatic aberrations of the person's eye causes the light of the first color component to focus pass a retina of the eye, wherein the first intensity is less than the second intensity.

Assignments (3)
ASSIGNMENT OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: JPMORGAN CHASE BANK, N.A.
To: CITIBANK, N.A.
Reel/Frame 050967/0138 →
PATENT SECURITY AGREEMENT Recorded Aug 22, 2019
From: MAGIC LEAP, INC.; MOLECULAR IMPRINTS, INC.; MENTOR ACQUISITION ONE, LLC
To: JP MORGAN CHASE BANK, N.A.
Reel/Frame 050138/0287 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2019
From: SAMEC, NICOLE ELIZABETH; MACNAMARA, JOHN GRAHAM; HARRISES, CHRISTOPHER M.; SCHOWENGERDT, BRIAN T.; ABOVITZ, RONY; BAERENRODT, MARK; TECHNICAL SOLUTIONS, INC.
To: MAGIC LEAP, INC.
Reel/Frame 049584/0749 →